AML with t(8;21): A Molecularly Defined Entity with Morphological Ambiguities

Online Makale

Online Hizmetlere Toplu Bakış Online Kayıt ve Konaklama Online Bilimsel Program Dernekler İçin... Referanslarımız Telefon ve e-posta Desteği Bildiri özeti nedir? Bildiri özeti nasıl hazırlanır? Bildiri özeti örnekleri Kabul mektubu örnekleri

Turkish Journal of Hematology

AML with t(8;21): A Molecularly Defined Entity with Morphological Ambiguities [Turk J Hematol]

Turk J Hematol. Ahead of Print: TJH-45945 | DOI: 10.4274/tjh.galenos.2025.2025.0341

AML with t(8;21): A Molecularly Defined Entity with Morphological Ambiguities

Smeeta Gajendra, Leena Gupta, Rani Sahoo
Laboratory Oncology, Dr. B.R.A.I.R.C.H, All India Institute of Medical Sciences, New Delhi, India

Keywords: Acute Myeloid Leukemia, t(8, 21)(q22;q22), RUNX1–RUNX1T1 Fusion, Atypical Chronic Myeloid Leukemia, Juvenile myelomonocytic leukemia, Cytogenetics, Molecular Diagnostics

Corresponding Author: Smeeta Gajendra, India

TOOLS